The present invention relates to a Clostridial neurotoxin for use in a method for treating an autoimmune disorder, comprising: administering an effective amount of the Clostridial neurotoxin to a location in proximity to the thymus gland of a patient to alleviate at least one symptom of the autoimmune disorder, thereby treating the autoimmune disorder.